Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adding Maraviroc to the HAART Regimen of HIV-infected Patients Who Are Well Controlled, and the Effect on CD4 Lymphocyte Counts

NCT02934022 is registered in ClinicalTrials.gov with Southern California Institute for Research and Education as lead sponsor.

NCT NCT02934022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02934022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adding Maraviroc to the HAART Regimen of HIV-infected Patients Who Are Well Controlled, and the Effect on CD4 Lymphocyte Counts
Lead sponsor
Southern California Institute for Research and Education
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2014
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection